background image

Paid Clinical Trials Texas

Discover 4,949 paid clinical trials in Texas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Featured

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

for
Insulin Resistance, Polycystic Ovary Syndrome, Hyperinsulinism,
Location: Houston TX
Sponsor: Ali Chappell

Sex: All

Age: 18+

Code: NCT05950282

Recruiting
Active & ResponsiveNew

Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia

for
Schizophrenia
Location: Little Rock AR, Richardson TX
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18 - 60

Code: NCT07680946

Phase2, Recruiting
Active & Responsive

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Neptune City NJ, Montreal, Syracuse NY, Ottawa, Toronto,
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT02468024

Phase3, Recruiting
Active & Responsive

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

for
Ulcerative Colitis
Location: London, Boston MA, Providence RI, Trois-Rivieres,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07186101

Phase2, Recruiting
Active & Responsive

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

for
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Location: Boston MA, Quebec, The Bronx NY, New York NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 12+

Code: NCT06338995

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

for
Breast Neoplasms
Location: Rimouski, Boston MA, New Haven CT, Quebec,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312176

Phase3, Recruiting
Active & Responsive

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

for
Amyotrophic Lateral Sclerosis
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: Prilenia

Sex: All

Age: 18 - 70+

Code: NCT07322003

Phase3, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

for
Alzheimer's Disease
Location: Halifax, East Providence RI, Newton MA, Quebec,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 60 - 70+

Code: NCT06976216

Phase3, Recruiting
Active & Responsive

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

for
Sjögren, Sjogren Disease, Sjogren's Syndrome
Location: Orlando FL, Memphis TN, Webster TX, Plano TX,
Sponsor: Cullinan Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07041099

Phase1, Recruiting
Active & Responsive

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

for
Metastatic Dedifferentiated Liposarcoma,
Location: Boston MA, Waterford CT, Guilford CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06422806

Phase3, Recruiting

Popular cities in Texas

With a broad healthcare network and leading medical research centers, Texas is a key location for a wide range of clinical trials. Major institutions such as MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and Texas Heart Institute are at the forefront of these studies.

Why choose Texas for clinical trials?

Common conditions studied in Texas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Texas